About Avertix Medical
Avertix Medical is a private company based in Eatontown, New Jersey. It has reported $121,293,444 raised in 11 offerings on Form D since December 2012.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | Sep 23, 2025 | $1,011,667of $5.0M target | 4 | $252K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 5, 2024 | Sep 9, 2024amended Mar 11, 2025 | $14,253,772of $22.6M target | 40 | $356K | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 31, 2024 | Aug 14, 2024 | $7,092,079of $28.4M target | 59 | $120K | EquityRule 506(b) | Form D ↗ |
| Oct 31, 2023 | Nov 13, 2023amended May 10, 2024 | $13,480,307of $15.0M target | 53 | $254K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 15, 2023 | Mar 1, 2023 | $34,252,457of $38.0M target | 82 | $417K | EquityRule 506(b) | Form D ↗ |
| Aug 22, 2022 | Sep 6, 2022 | $6,000,000of $6.5M target | 20 | $300K | DebtRule 506(b) | Form D ↗ |
| Jul 30, 2021 | Aug 17, 2021 | $3,857,162of $7.5M target | 39 | $98,902 | DebtRule 506(b) | Form D ↗ |
| Mar 29, 2019 | Apr 1, 2019 | $10,000,000of $15.0M target | 56 | $178K | EquityRule 506(b) | Form D ↗ |
| Jan 7, 2019 | Jan 17, 2019 | $600,000of $2.5M target | 2 | $300K | Equity, DebtRule 506(b) | Form D ↗ |
| Nov 25, 2014 | Dec 8, 2014 | $10,215,000of $20.5M target | 22 | $464K | DebtRule 506(b) | Form D ↗ |
| Dec 5, 2012 | Dec 13, 2012amended Dec 16, 2013 | $20,531,000of $20.5M target | 23 | $892K | Equity, Debt, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Total, 11 offerings | $121,293,444 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avertix Medical's Form D filed Sep 23, 2025.
Earlier filings also listed Ross Haghighat (executive officer and director, last listed Mar 2025), Victor Whitman (director, last listed Aug 2024), Phillip Torrence (secretary, last listed Aug 2024), David Fischell (director, last listed Aug 2024), Andrew Taylor (director, last listed Aug 2024), Brad Snow (ceo and director, last listed Sep 2022), Robert Fischell (director, last listed Jan 2019) and Frank Fischer (director, last listed Jan 2019).